FDA vs EU MDR

As emerging markets open their doors to innovative healthcare technologies, Argentina is quickly becoming a top destination for MedTech expansion. In this post, we speak with Matias, Arazy Group’s Corporate Sales Manager and General Manager of the Argentine office, who shares what MedTech companies need to know about navigating regulatory access, choosing the right strategy,…

Lately, I’ve been reflecting on how often companies underestimate the complexity of global regulatory submissions. Everyone’s trying to move fast—but fast doesn’t always mean strategic. And honestly, it’s not the big, obvious challenges that cause trouble. The smaller, overlooked assumptions end up delaying launches or putting compliance at risk.  After years of working with clients…